Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Alpha9 Theranostics | 23 Oct 2024 | Vancouver, British Columbia, Canada | |||
MBX Biosciences | $63M | 05 Aug 2024 | Indiana, United States | ||
Attovia Therapeutics | $105M | 09 May 2024 | Fremont, California, United States | ||
Enlaza Therapeutics | $100M | 30 Apr 2024 | La Jolla, California, United States | ||
Diagonal Therapeutics | $128M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Sudo Biosciences | $30M | 13 Feb 2024 | Menlo Park, California, United States | ||
Radionetics Oncology | $52M | 03 Jan 2024 | California City, California, United States | ||
Sudo Biosciences | $116M | 20 Dec 2023 | Menlo Park, California, United States | ||
Lassen Therapeutics | $85M | 19 Dec 2023 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Alpha9 Theranostics | 23 Oct 2024 | Vancouver, British Columbia, Canada | |||
MBX Biosciences | $63M | 05 Aug 2024 | Indiana, United States | ||
Attovia Therapeutics | $105M | 09 May 2024 | Fremont, California, United States | ||
Enlaza Therapeutics | $100M | 30 Apr 2024 | La Jolla, California, United States | ||
Diagonal Therapeutics | $128M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Sudo Biosciences | $30M | 13 Feb 2024 | Menlo Park, California, United States | ||
Radionetics Oncology | $52M | 03 Jan 2024 | California City, California, United States | ||
Sudo Biosciences | $116M | 20 Dec 2023 | Menlo Park, California, United States | ||
Lassen Therapeutics | $85M | 19 Dec 2023 | San Diego, California, United States |